James O. Baffoe

James O. Baffoe

Auto-generated profile, based on publicly available information

James O. Baffoe

Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, Austin, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2023 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
COChinyere Okoh
Chinyere Okoh
LMLeticia R. Moczygemba
Leticia R. Moczygemba
WTWhitney Thurman
Whitney Thurman
CBCarolyn Brown
Carolyn Brown
CHChristopher Hanson
Christopher Hanson
JBJames O. Baffoe
James O. Baffoe
Background: Community Paramedicine is an evolving community-based model that expands paramedic roles from emergency and transport care to a focus on non-emergent and preventive health services tailored to local community needs. Though community paramedicine is a growing field and acceptance is gradually increasing, there is limited information on community paramedics (CPs) perceptions of their expanded roles. The study’s aim is to assess CPs’ perceptions about their training, roles, role clarity, role readiness, role satisfaction, professional identity, interprofessional collaboration, and the future of the community paramedicine care model. Methods: Using the National Association of Emergency Medical Technicians-mobile integrated health (NAEMT-MIH) listserv, a cross-sectional survey was conducted in July/August 2020 using a 43-item web-based questionnaire. Thirty-nine questions evaluated CPs’ training, roles, role clarity, role readiness, role satisfaction, professional identity, interprofessional collaboration, and program/work characteristics. Four open-ended questions examined perceptions of the future of community paramedicine care models and challenges/opportunities encountered during the COVID-19 pandemic. Data was analyzed using Spearman’s correlation, Wilcoxon Mann–Whitney U, and Kruskal–Wallis tests. Open-ended questions were analyzed using qualitative content analyses. Results: Responses from fifty-seven CPs were analyzed. Most (80%) completed didactic and/or clinical training. Nearly all respondents (96.5%) performed health assessments; only 38.6% administered vaccines. Overall, participants were neutral about their role readiness with a mean score of 3.3/5.0. The mean role clarity was 15.5 (range 4–29; higher scores = higher clarity), professional identity was 46.8 (range 30–55; higher scores = higher identity), role satisfaction was 4.4/5 with 5 = very satisfied, and interprofessional collaboration was 9.5/10 (10 = very important). Role clarity training (rho = 0.4, p = 0.0013) and higher interprofessional collaboration (rho = 0.4, p = 0.0015) were found to be significantly associated with the enhancement of professional identity. Respondents who completed training showed higher role satisfaction compared to those who did not (p = 0.0114). COVID-19 challenges included keeping up with emerging policies/procedures, CPs’ well-being, and inadequate funding to meet service needs; opportunities identified included service delivery expansion and CPs meeting community needs in a flexible manner. Respondents reported that sustainable payment models, expanding services, and geographic reach were important to the future of community paramedicine. Conclusions: Interprofessional collaboration is important to fulfill CPs roles. Role clarity and readiness could be improved, which aligns with the emerging nature of community paramedicine. The future of the community paramedicine care model is dependent on funding and expanding reach of services.

28 September 2023 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
LMLeticia R. Moczygemba
Leticia R. Moczygemba
RSReshmi L. Singh
Reshmi L. Singh
JBJames O. Baffoe
James O. Baffoe

18 March 2025 in JMIR Formative Research
Verified
Journal Article
Open access
HMHannah P McCullough
Hannah P McCullough
LMLeticia R. Moczygemba
Leticia R. Moczygemba
AAAnton Avanceña
Anton Avanceña
JBJames O Baffoe
James O Baffoe
Background: The Interactive Care Coordination and Navigation (iCAN) mobile health intervention aims to improve care coordination and reduce hospital and emergency department visits among people experiencing homelessness. Objective: This study aimed to conduct a three-part economic evaluation of iCAN, including a (1) cost analysis, (2) exploratory financial cost-benefit analysis, and (3) budget impact analysis (BIA). Methods: We collected cost and expenditure data from a randomized controlled trial of iCAN to conduct a cost analysis and exploratory financial cost-benefit analysis. Costs were classified as startup and recurring costs for participants and the program. Startup costs included participant supplies for each participant and SMS implementation costs. Recurring costs included the cost of recurring services, SMS text messaging platform maintenance, health information access fees, and personnel salaries. Using the per participant per year (PPPY) costs of iCAN, the minimum savings reduction in the average health care costs among people experiencing homelessness that would lead to a benefit-cost ratio >1 for iCAN was calculated. This savings threshold was calculated by dividing the PPPY cost of iCAN by the average health care costs among people experiencing homelessness multiplied by 100%. The benefit-cost ratio of iCAN was calculated under different savings thresholds from 0% (no savings) to 50%. Costs were calculated PPPY under different scenarios, and the results were used as inputs in a BIA. A probabilistic sensitivity analysis was conducted to incorporate uncertainty around cost estimates. Costs are in 2022 US $. Results: The total cost of iCAN was US $2865 PPPY, which was made up of US $265 in startup (9%) and US $2600 (91%) in recurring costs PPPY. The minimum savings threshold that would cause iCAN to have a positive return on investment is 7.8%. This means that if average health care costs (US $36,917) among people experiencing homelessness were reduced by more than 7.8% through iCAN, the financial benefits would outweigh the costs of the intervention. When health care costs are reduced by 25% ($9229/$36,917; equal to 56% [$9229/$16,609] of the average cost of an inpatient visit), the benefit-cost ratio is 3.22, which means that iCAN produces US $2.22 in health care savings per US $1 spent. The BIA estimated that implementing iCAN for 10,250 people experiencing homelessness over 5 years would have a financial cost of US $28.7 million, which could be reduced to US $2.2 million if at least 8% ($2880/$36,917) of average health care costs among people experiencing homelessness are reduced through the intervention. Conclusions: If average costs of emergency department and hospital visits among people experiencing homelessness were reduced by more than 7.8% ($2880/$36,917) through iCAN, the financial benefits would outweigh the costs of the intervention. As the savings threshold increases, it results in a higher benefit-cost ratio.

9 December 2025 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
JBJames O. Baffoe
James O. Baffoe
LMLeticia R. Moczygemba
Leticia R. Moczygemba
AAAnton Avanceña
Anton Avanceña
CBCarolyn M. Brown
Carolyn M. Brown
ESEmily M. Seales
Emily M. Seales

10 June 2026 in Clinical Drug Investigation
Verified
Journal Article
Open access
PDF file
AKAhmed Saleh Kenawy
Ahmed Saleh Kenawy
JBJames O. Baffoe
James O. Baffoe
CPChanhyun Park
Chanhyun Park
Background Cancer diagnoses impact adherence to antidiabetic medications, but limited research has focused on patients with prostate cancer and type 2 diabetes (T2DM). We investigated adherence trajectories to oral antidiabetic medications one year before and after a prostate cancer diagnosis and identified risk factors. Methods This retrospective cohort study used the 2011–2021 MarketScan Commercial and Medicare Supplemental databases. We included newly diagnosed prostate cancer patients with T2DM with continuous insurance enrollment. We applied group-based trajectory modeling with a beta distribution to evaluate adherence patterns before and after prostate cancer diagnosis. Model covariates included age, total number of medications, number of antidiabetic medications, the Charlson Comorbidity Index (CCI), cost, insurance type, and complicated diabetes from the year before diagnosis. Metastasis and cancer treatments were included in the model after diagnosis. Results The study included 7864 patients (mean age = 74.5 ± 7.1). Three adherence trajectories were identified before diagnosis: consistently high adherence, steady decliners, and consistently low adherence. After diagnosis, a fourth trajectory revealing a moderate decline emerged. Over half (61.2%) changed adherence patterns after diagnosis. Among those with consistently high adherence before diagnosis, 57.8% transitioned to a lower adherence trajectory. In contrast, 58.5% of steady decliners and 57.6% of consistently low adherents transitioned to a higher adherence trajectory after diagnosis. Predictors of high adherence included older age, fewer antidiabetic medications, lower CCI, and complicated diabetes before diagnosis. After diagnosis, fewer antidiabetic medications and complicated diabetes remained predictive of high adherence. Conclusion Patterns of adherence to oral antidiabetic medications undergo substantial changes after a prostate cancer diagnosis. Targeted interventions are needed to support and facilitate effective diabetes management in this population.